Transfusion Medicine

Papers
(The median citation count of Transfusion Medicine is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-06-01 to 2024-06-01.)
ArticleCitations
Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels52
Impact of COVID‐19 in the attendance of blood donors and production on a Brazilian Blood Centres18
Clinical Implication of Immunohaematological Tests in ABO haemolytic disease of newborn: Revisiting an old disease15
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection14
Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study13
Practical approach to transfusion management of post‐partum haemorrhage12
Trust and distrust: Identifying recruitment targets for ethnic minority blood donors11
Effect of leukoreduction on transfusion‐related immunomodulation in patients undergoing cardiac surgery11
Convalescent plasma for COVID‐19: Back to the future11
Absence of SARS‐CoV‐2 viraemia in a blood donor with COVID‐19 post‐donation11
Impact of severe acute respiratory syndrome on blood services and blood in Hong Kong in 200311
Erythropoiesis‐stimulating agents as replacement therapy for blood transfusions in critically ill patients with anaemia: A systematic review with meta‐analysis11
Machine learning for predicting preoperative red blood cell demand11
Motivators of and barriers to becoming a COVID‐19 convalescent plasma donor: A survey study10
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective10
Hydrops fetalis associated with anti‐CD36 antibodies in fetal and neonatal alloimmune thrombocytopenia: Possible underlying mechanism10
Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID‐19): Evidence‐10
Adherence to blood product transfusion guidelines—An observational study of the current transfusion practice in a medical intensive care unit9
Massive transfusion protocols in paediatric trauma population: A systematic review9
Inter‐donor variability in deformability of red blood cells in blood units8
A review of whole‐blood donors' willingness, motives, barriers and interventions related to donating another substance of human origin8
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis8
E‐learning/online education in transfusion medicine: A cross‐sectional international survey8
Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections8
Risk of hepatitis‐E virus infections among blood donors in a regional blood transfusion centre in western India8
Beyond COVID‐19 and lessons learned in the United States7
Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India7
Effect of the first year of COVID‐19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system7
Convalescent plasma and COVID‐19: Time for a second—second look?7
Safety and efficacy of COVID‐19 convalescent plasma in severe pulmonary disease: A report of 17 patients7
A UK national survey of prophylactic platelet transfusion thresholds in non‐bleeding, critically ill adults6
Association between the length of storage of transfused leukoreduced red blood cell units and hospital‐acquired infections in critically ill children: A secondary analysis of the TRIPICU st6
Development and validation of a nomogram to predict intraoperative blood transfusion for gastric cancer surgery6
Transfusion in critical care: Past, present and future6
Effect of patient blood management system and feedback programme on appropriateness of transfusion: An experience of Asia's first Bloodless Medicine Center on a hospital basis6
Pulmonary complications of transfusion: Changes, challenges, and future directions6
Prophylactic tranexamic acid use in non‐cardiac surgeries at high risk for transfusion6
Fertility and pregnancy in Iranian thalassemia patients: An update on transfusion complications6
Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction6
Transfusion therapy of neonatal and paediatric patients: They are not just little adults5
Monitoring iron stores in Icelandic blood donors from 1997 through 20195
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach5
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review5
Comparison of ABO antibody titration, IgG subclasses and qualitative haemolysin test to reduce the risk of passive haemolysis associated with platelet transfusion5
Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab5
Assessment the knowledge of blood transfusion in Iranian nurses of Tehran's hospitals5
Extended red blood cell matching for all transfusion recipients is feasible5
Alloimmunisation rate of patients on Daratumumab: A retrospective cohort study of patients in England5
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England5
Red blood cell transfusion in myelodysplastic syndromes: A systematic review4
Passenger lymphocyte syndrome with severe haemolysis misdiagnosed/treated as cold agglutinin syndrome: Analysis of case and diagnostic error4
Improving blood‐prescribing decisions: Evaluating the efficacy of a blood guidelines app4
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation4
Sickle cell disease patients in two London trusts: Genotyping including RH variants4
Role of ABO blood system in COVID‐19: Findings from a southern Italian study4
Probable cefepime‐induced immune mediated hemolytic anaemia4
Histo‐blood group A is a risk factor for severe COVID‐194
Convalescent plasma for COVID‐19: Donor demographic factors associated high neutralising antibody titres4
ABO‐incompatible convalescent plasma transfusion: Yes, you can4
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England4
Impact of Covid‐19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes4
Skin flora and bacterial contamination of diversion pouch and recovered platelet components in Moroccan blood donors4
The haemoglobinopathy survey: The reality of transfusion practice in sickle cell disease and thalassaemia in England4
Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China4
Recovery of platelet‐rich red blood cells and acquisition of convalescent plasma with a novel gravity‐driven blood separation device4
Emergency response to COVID‐19 epidemic: One Chinese blood centre's experience3
Kinetics of anti‐SARS‐COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability3
Transfusion requirement prediction score for patients undergoing cardiac surgery: An experience from a tertiary care set‐up from South India3
Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis3
Confirmed non‐invasive prenatal testing for foetal Rh blood group genotyping along with bi‐allelic short insertion/deletion polymorphisms as a positive internal control3
Blood group P1 prediction using multiplex PCR genotyping of A4GALT among Thai blood donors3
Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa3
Screening of at‐risk blood donors for Chagas disease in non‐endemic countries: Lessons from a 2‐year experience in Tuscany, Italy3
Utility of pre‐operative haemoglobin concentration to guide peri‐operative blood tests for hip and knee arthroplasty: A decision curve analysis3
Poster session3
London 2017: Lessons learned in transfusion emergency planning3
The contribution and potential of older blood donors in Asia Pacific regions3
A physiology‐based trigger score to guide perioperative transfusion of allogeneic red blood cells: A multicentre randomised controlled trial3
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature3
The lack of anti‐PF4 antibodies in convalescent plasma from COVID‐19 infected blood donor3
Patterns of paediatric massive blood transfusion protocol use in trauma and non‐trauma patients3
Prospective audit of blood transfusion request forms and continuing medical education to optimise compliance of clinicians in a hospital setting3
Impact of microbial contamination of haematopoietic stem cells on post‐transplant outcomes: A retrospective study from tertiary care centre in India3
A survey of nurses to assess transfusion practice at the bedside using an electronic identification system: Experience at a university hospital2
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient2
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study2
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia2
Divergence in phenotyping and genotyping analysis of the Lewis histo‐blood group system2
Anaphylactic reaction after pre‐deposit autologous blood transfusion2
Blood collection failures from a blood establishment perspective2
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors2
HLA‐DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization2
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre2
Low‐titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experience2
Validation of an apoptosis assay for extracorporeal photopheresis2
Implementation of an anaemia walk‐in clinic: Feasibility and preliminary data from the Orthopedic University Hospital2
Role of donor self‐reporting in securing blood safety during COVID‐19 pandemic2
Demographic, clinical, and biochemical predictors of pica in high‐intensity blood donors2
D variants in the population of D‐negative blood donors in the north‐eastern region of Croatia2
A prospective interventional study to assess the impact of a ‘structured compact training’ on knowledge and skills of safe blood transfusion practices among nurses working in a tertiary care institute2
Anti‐HBc and hepatitis B virus DNA among HBsAg‐negative blood donors from the main central blood bank units in Eastern Libya2
Prevalence of anaemia in patients discharged from the paediatric intensive care unit2
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis2
The central blood volume as measured by thoracic electrical impedance and plasma proANP is not compromised by donation of 900 mL of blood in men2
Life in times of COVID‐192
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity2
Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia2
A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β‐thalassemia during perinatal transfusion2
ABO(H) and Lewis blood group substances and disease treatment2
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia2
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants2
Implementation of high‐throughput non‐invasive prenatal testing for fetal RHD genotype testing in England: Results of a cross‐sectional survey of maternity units and expert interview2
Rh deficiency syndrome with anti Rh‐29 in a multiparous lady causing transfusion reactions2
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors2
Detection and analysis of blood donors seropositive for syphilis2
Parvovirus B19 and recipient safety: is it time to do more?2
Re‐examine the transfusion transmitted risk of SARS‐CoV‐2 virus during a major COVID‐19 outbreak in 20222
Effects of storage on quality and function of acid‐treated platelets with reduced HLA Class I surface expression2
BGvar: A comprehensive resource for blood group immunogenetics2
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood2
Acute haemolytic transfusion reaction after transfusion of fresh frozen plasma in a neonate—Preventable by using solvent/detergent‐treated pooled plasma?1
Investigating non‐immune haemolytic transfusion reactions in surgical patients1
Cold agglutinin syndrome in a patient with anaemia and beta‐thalassemia trait1
1
Notes from the Basho of the blood service1
How do we translate gaps and unmet needs of blood management for thalassemia into a collaborative implementation framework?1
Red blood cell alloimmunisation in sickle cell disease patients in the Democratic Republic of the Congo1
Using a scenario approach to assess for the current and future demand of immunoglobulins: An interview and literature study from The Netherlands1
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major1
Utility of rotational thromboelastometry in the management of massive haemorrhage at a regional Australian hospital1
The impact of pathogen‐reduced platelets in acute leukaemia treatment on the total blood product requirement: a subgroup analysis of an EFFIPAP randomised trial1
Comparing transfusion practice at multiple hospitals using electronically collected and analysed data1
Improved detection of hepatitis C virus‐positive blood donors and determination of infection status1
Validation of the Sysmex XN analyser and Blood Bank mode for the quality and safety of donor blood and transfusion products1
Therapeutic apheresis and non‐blood donor related apheresis current practices at various blood centres of healthcare organisations of India: A brief online survey1
Accelerated erythrocyte destruction mimicking post‐transfusion hyperhaemolysis in the course of uncomplicated vaso‐occlusive crisis associated with sickle cell disease1
On consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities1
Donor oocyte‐facilitated reproduction: Time to revisit the BSH antenatal guidelines?1
Congress report: Online workshop on assessment of technical files for blood screening in vitro diagnostics for sub‐Sahara African countries1
Trend in seroprevalence of HTLV‐1/2 in Taiwanese blood donors—A 10‐year follow‐up1
The need for and challenges of comparing SARS‐CoV‐2 antibody assays1
Severe intracranial haemorrhage in neonatal alloimmune thrombocytopenia due to antibodies against human platelet antigen 1b: Case report and literature review1
Lessons learned from the CONCOR‐1 trial1
Preventing antibody positive delayed hemolytic transfusion reactions in sickle cell disease: Lessons learned from a case1
A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza1
D‐‐phenotype due to RHD‐RHCE hybrid transcript in a case of severe haemolytic disease of newborn with anti‐Rh 17(Hrₒ) antibodies1
SARS in Canada: Lessons learned for the blood operator1
Residual risk estimates of transfusion transmissible hepatitis B, hepatitis C and human immunodeficiency virus using nucleic acid testing yield/window period model in an Indian setting1
Improvement of the understanding of blood donors with human T‐cell leukaemia virus type 1 using a new information booklet1
Molecular validation of pathogen‐reduction technologies using rolling‐circle amplification coupled with real‐time PCR for torquetenovirus DNA quantification1
Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso1
Knowledge and attitudes of apheresis donors regarding apheresis blood donation1
Improvement of platelet preservation by inhibition of TRPC61
Pathogen inactivation treatment of triple‐dose apheresis platelets with amotosalen and ultraviolet a light1
2020: A year we will remember1
Reginald Saxton: An unlikely pioneer of battleground blood transfusion1
Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units1
Potential clinical value of cryopreserved haematopoietic precursors stored longer than 20 years1
A forecasting model to estimate the drop in blood supplies during the SARS‐CoV‐2 pandemic in Italy1
Abstracts for the Australian and New Zealand Society of Blood Transfusion (ANZSBT) stream of the BLOOD 2022 Meeting 11th – 14th September 2022, Sydney, Australia1
Drivers of blood use in paediatric trauma: A retrospective cohort study1
Blood loss and transfusion risk in intramedullary nailing for subtrochanteric fractures1
Real world reduction in red cell transfusion with restrictive transfusion threshold in haematology inpatients1
1
Insights from developing and evaluating the NHS blood choices transfusion app to support junior and middle‐grade doctor decision making against guidelines1
Hyperhaemolysis caused by anti‐HI antibodies in a patient with myelodysplastic syndrome following a first ever red cell transfusion1
Risks associated with perioperative anaemia and perioperative blood transfusion in patients undergoing neurosurgical operation1
Time to be proactive about passive D: Distinguishing anti‐D alloimmunisation from RhIG1
Characterising IndianRhDvariants by serological and molecular methods1
Sample collection for pre‐transfusion crossmatching: Benefits of using an electronic identification system1
COP27 Climate Change Conference: Urgent action needed for Africa and the world1
Changing red blood cell transfusion practice in obstetrics and gynaecology: A before and after study of hospital‐wide education1
A Houdini act: Transient loss of Jka resulting in anti‐Jk3 antibody formation1
Designing and testing an ethnic‐ancestry question for Australian blood donors: Acceptability, feasibility, and understanding1
Comparison of European recommendations about patient blood management in postpartum haemorrhage1
A challenge for blood management: A patient presenting anti‐Vel antibody undergoing orthotopic liver transplantation1
The activity of labile coagulation factors and fibrinogen in thawed plasma during a 5 day storage period in the hospital blood bank refrigerator1
Iron deficiency in whole blood donors in a resource‐poor setting: A cross‐sectional study in Uganda1
Successful haematopoietic progenitor cell collection by plerixafor in combination with reduced dose granulocyte colony‐stimulating factor for severe hypoxemia provoked by high‐dose granulocyte colony‐1
SARS‐CoV‐2‐associated warm autoimmune haemolytic anaemia in an immunosuppressed patient: The trend continues1
Blood transfusion demands in a tertiary otolaryngology, head and neck centre: A 5‐year retrospective cohort study1
An assessment of the management of anaemia in acute care settings in the United Kingdom: The value of a collaborative approach1
Volume of packed red blood cells and fresh frozen plasma is associated with intraoperative hypocalcaemia during large volume intraoperative transfusion1
High B‐cell activating factor levels in multi‐transfused thalassemia patients1
Evaluating automated titre score as an alternative to continuous flow analysis for the prediction of passive anti‐D in pregnancy1
Placebo and nocebo effects in transfusion medicine1
Safe handovers: Safe patients‐why good quality structured handovers in the transfusion laboratory are important1
Severe acute haemolytic transfusion reaction secondary to a plasma incompatible group B platelet transfusion0
Issue Information0
Viral safety of recovered plasma for contract fractionation; an Iranian experience, 2006–20150
Molecular characterisation ofRhDvariants in North Indian blood donor population0
Charles Waller and Edward Doubleday—Colleagues of James Blundell and early supporters of blood transfusion0
Platelets inhibit erythrocyte invasion by Plasmodium falciparum at physiological platelet:erythrocyte ratios0
Exploring the increasing need for plasma collection: Perspectives of voluntary nonremunerated donors on payment for plasma in Canada0
Corrigendum0
0
Suggested blood donor deferral strategy regarding hepatitis B infections in China0
Anti‐Gya and pregnancy0
Issue Information0
A nait‐associated and previously unreported mutation in the ITGB3 gene with a low frequency in the local population0
Wednesday 14 September 2022 Simultaneous Session0
Intravenous immunoglobulin alteration in response to adverse reactions in neurological conditions: A retrospective cohort study0
Hemolysis during therapeutic plasma exchange: A rare phenomena0
Reactions to serum eye drops—New Zealand experience and review of the literature0
A multidisciplinary comparison of transfusion and perioperative support for high‐risk cardiac surgery at three large academic centres in North America0
0
Discrepancies among studies reporting the prevalence of positive direct antiglobulin tests in the COVID‐19 patient population0
Individual and environmental determinants of serum ferritin levels: A structural equation model0
0
Emergency paediatric blood transfusion practices in Mozambique0
Using trends and outliers in managing delayed transfusions0
Genetic profile of RHCE, Kell, Duffy, Kidd, Diego and MNS hybrid glycophorins blood groups in ethnic northeastern Thais: Alleles, genotypes and risk of alloimmunisation0
0
Evidence cornered: Transfusion evidence summary—efficacy and safety of early administration of 4‐factor prothrombin complex concentrate in patients with trauma at risk of massive transfusio0
Issue Information0
Plenary I0
Wednesday 11 October 2023 Simultaneous Sessions0
The influence of the COVID‐19 pandemic on blood donation and supply in China0
Issue Information0
Issue Information0
Author Index0
Reflections of a re‐engaged donor. A response to ‘on consciousness of the decision to discontinue blood donation: Intention to return and effective recovery activities’0
Transfusion Evidence Synopsis: Platelet transfusion before CVC placement in patients with thrombocytopenia (PACER trial)0
Corrigendum0
Apparent changes in RhD status during pregnancy: A case study of weak D variant due to RHD*DAU‐20
Issue Information0
Chikungunya virus seroprevalence in asymptomatic blood donors during an outbreak in the Federal District of Brazil0
Assessing motivations for non‐living and living organ donation among individuals with and without a history of blood donation0
Anti‐AnWj antibody induced haemolytic transfusion reaction in a patient with primary acquired pure red cell aplasia0
Efficacy and safety of BT595 (10% human intravenous immunoglobulin) in adult patients with chronic immune thrombocytopenia0
Optimizing blood utilization: Experience of blood redistribution policy from a tertiary care hospital based blood centre0
Surgical patients' perception about risks related to blood transfusion: A cross‐sectional survey0
Frequency of red blood cell phenotypes from genotyped Australian blood donors0
Fresh frozen plasma: Beyond coagulation factor content0
Virological safety of the UK blood supply in the era of individual risk assessments and HIV PrEP0
An accurate genetic assay to identify human neutrophil antigen 2 deficiency0
The ongoing dilemma of prophylactic platelet transfusions pre‐procedure and the development of evidence‐based recommendations0
Author Index0
Autologous umbilical cord blood for red cell concentrate transfusion in preterm infants in the era of delayed cord clamping: An uncontrolled clinical trial0
Role of disruptions in O RhD negative donations in Colombia on increasing maternal mortality ratio from haemorrhage0
Issue Information0
Evidence cornered: Preoperative intravenous iron to treat anaemia before major abdominal surgery (PREVENTT trial)0
0
Evaluation of two temperature storage conditions for full blood count samples from Lifeblood's donors0
0
Bone marrow changes in a fatal case of transfusion associated—Graft versus host disease0
2021: That was the year that was0
Prevalence and incidence of transfusion‐transmissible infections among blood donors in Malawi: A population‐level study0
Issue Information0
Reflection from managing blood supply during social unrest0
0.06964898109436